Human TGF beta 2 Recombinant Protein

Also known as: TGFB2, Transforming Growth Factor beta 2, TGFbeta2

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 14-8368

Cat. No. Size
14-8368-62 5 ug
14-8368-80 25 ug
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human TGF beta 2 Recombinant Protein.

Description

Description: Human Transforming Growth Factor-β2 (TGF- β2) is a member of a superfamily of disulfide-linked homodimeric proteins secreted as latent proteins and stored at the cell surface and extracellular matrix. The bioactive TGF-β2 is released from a latent complex by proteolytic processing and conformation changes. TGF-β2 regulates cell proliferation, growth, differentiation and motility as well as synthesis and deposition of the extracellular matrix. TGF-βs is also involved in embryogenesis, tissue remodeling and wound healing. TGF-β2 has 97% identity at the amino acid level. Functionally, human TGF-β2 can stimulate mouse cells.

Details
Reactivity Human
Purity > 98%, as determined by SDS-PAGE
Molecular Mass Recombinant human TGF-\beta2 is a 23.7 kDa protein with each subunit containing 101 aa residues.
Endotoxin Level Less than 0.01 ng/ug cytokine as determined by the LAL assay.
Reported Applications Cytokine Bioassays
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
34-8368 Human TGF beta 2 Recombinant Protein Carrier-Free FA RUO
References

References: Fantini MC, Becker C, Tubbe I, Nikolaev A, Lehr HA, Galle P, Neurath MF. TGF-beta – induced Foxp3+ regulatory T cells suppress Th1-mediated experimental colitis. Gut. 2006 May;55(5):671-80.

Peng Y, Laouar Y, Li MO, Green EA, Flavell RA. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4572-7.

Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation ex vivo of TGF-b-producing regulatory T cells from CD4+CD25- precursors. J Immunol. 2002 Oct 15;169(8):4183-9.

Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors. 1993;8(1):1-9. Review.

Miyazono K, Heldin CH. Structure, function and possible clinical application of transforming growth factor-beta. J Dermatol. 1992 Nov;19(11):644-7.